4//SEC Filing
SIECZKAREK MARK M 4
Accession 0001437749-19-015525
CIK 0001389545other
Filed
Aug 5, 8:00 PM ET
Accepted
Aug 6, 8:18 AM ET
Size
4.6 KB
Accession
0001437749-19-015525
Insider Transaction Report
Form 4
SIECZKAREK MARK M
Director
Transactions
- Award
Common Stock
2019-07-30+167,938→ 1,156,883 total
Footnotes (1)
- [F1]On July 30, 2019, Mr. Sieczkarek was issued 167,938 restricted stock units ("RSUs") with a fair market value equal to $220,000 from the Company's 2017 Omnibus Incentive Plan, which were immediately fully vested into common stock. Such RSUs were granted to Mr. Sieczkarek in relation to a Severance Agreement and General Release, as disclosed in the Company's Current Report on Form 8-K, filed with the SEC on July 25, 2019.
Documents
Issuer
NovaBay Pharmaceuticals, Inc.
CIK 0001389545
Entity typeother
Related Parties
1- filerCIK 0001188738
Filing Metadata
- Form type
- 4
- Filed
- Aug 5, 8:00 PM ET
- Accepted
- Aug 6, 8:18 AM ET
- Size
- 4.6 KB